QS Investors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$5.14M Sell
41,433
-6,047
-13% -$759K 0.06% 233
2021
Q1
$5.61M Sell
47,480
-644
-1% -$75.5K 0.07% 222
2020
Q4
$5.64M Sell
48,124
-2,896
-6% -$319K 0.07% 205
2020
Q3
$5.3M Sell
51,020
-5,194
-9% -$522K 0.07% 192
2020
Q2
$5.16M Sell
56,214
-3,050
-5% -$292K 0.07% 209
2020
Q1
$5.34M Sell
59,264
-15,043
-20% -$1.6M 0.09% 188
2019
Q4
$8.51M Sell
74,307
-11,835
-14% -$1.3M 0.09% 176
2019
Q3
$9.36M Buy
86,142
+4,109
+5% +$429K 0.1% 152
2019
Q2
$7.99M Buy
82,033
+3,250
+4% +$297K 0.09% 160
2019
Q1
$7.18M Buy
78,783
+12,478
+19% +$1.12M 0.08% 167
2018
Q4
$6.03M Buy
66,305
+784
+1% +$73.3K 0.08% 173
2018
Q3
$6.45M Sell
65,521
-3,180
-5% -$294K 0.06% 205
2018
Q2
$5.88M Sell
68,701
-4,267
-6% -$356K 0.06% 240
2018
Q1
$5.85M Sell
72,968
-255
-0.3% -$21K 0.06% 210
2017
Q4
$5.91M Sell
73,223
-1,442
-2% -$115K 0.06% 249
2017
Q3
$5.81M Sell
74,665
-32,057
-30% -$2.66M 0.05% 255
2017
Q2
$9.47M Sell
106,722
-412
-0.4% -$34.7K 0.08% 151
2017
Q1
$8.63M Buy
107,134
+8,549
+9% +$668K 0.07% 165
2016
Q4
$7.02M Sell
98,585
-843
-0.8% -$66.2K 0.06% 242
2016
Q3
$8.59M Sell
99,428
-2,102
-2% -$183K 0.07% 233
2016
Q2
$8.81M Sell
101,530
-2,738
-3% -$221K 0.08% 231
2016
Q1
$7.82M Sell
104,268
-29,319
-22% -$2.21M 0.07% 258
2015
Q4
$10.3M Sell
133,587
-6,851
-5% -$516K 0.1% 186
2015
Q3
$9.4M Sell
140,438
-11,968
-8% -$881K 0.1% 191
2015
Q2
$11.3M Sell
152,406
-7,762
-5% -$593K 0.14% 170
2015
Q1
$12.5M Sell
160,168
-29,464
-16% -$2.23M 0.14% 165
2014
Q4
$13.7M Buy
189,632
+157,592
+492% +$10.9M 0.16% 159
2014
Q3
$1.99M Sell
32,040
-5,500
-15% -$350K 0.05% 241
2014
Q2
$2.39M Buy
37,540
+5,418
+17% +$329K 0.06% 243
2014
Q1
$1.98M Sell
32,122
-5,500
-15% -$320K 0.06% 257
2013
Q4
$2.16M Buy
37,622
+1,500
+4% +$85.1K 0.08% 202
2013
Q3
$1.92M Sell
36,122
-5,578
-13% -$300K 0.08% 222
2013
Q2
$2.2M Buy
+41,700
New +$2.06M 0.08% 271

Other funds holding MDT

QS Investors's MDT Position: Q2 2021 in Review

QS Investors reduced its Medtronic (MDT) stake by 13% in Q2 2021, selling an estimated $759K and leaving 41,433 shares worth $5.14M. The position accounts for 0.06% of the portfolio, ranked #233.

QS Investors first reported a position in MDT in Q2 2013 and has held it in 33 quarters since. The position peaked at $13.7M in Q4 2014. 2,003 funds tracked by Wall St. Rank hold MDT as of Q2 2021.

  • QS Investors held 41,433 shares of Medtronic worth $5.14M as of Q2 2021.
  • QS Investors sold 6,047 Medtronic shares in Q2 2021, an estimated $759K.
  • Medtronic made up 0.06% of QS Investors's portfolio in Q2 2021, its #233 holding.
  • QS Investors first reported a position in Medtronic in Q2 2013 and has held it in 33 quarters since.
  • QS Investors's Medtronic position peaked at $13.7M in Q4 2014.
  • 2,003 funds tracked by Wall St. Rank held Medtronic as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.